21 CFR Part 11
FDA requirements for electronic records and electronic signatures. View requirements mapping
Cohera is designed from the ground up to support regulatory compliance in pharmaceutical environments. This section provides detailed documentation on how Cohera meets regulatory requirements and guidance for your validation activities.
Cohera supports compliance with major pharmaceutical regulations:
21 CFR Part 11
FDA requirements for electronic records and electronic signatures. View requirements mapping
EU GMP Annex 11
European requirements for computerized systems in GMP environments. View requirements mapping
GAMP 5
Risk-based approach to compliant GxP computerized systems. View category classification
Cohera implements compliance controls as core platform features, not add-ons:
| Principle | Cohera Implementation |
|---|---|
| Attributable | Every action linked to authenticated user with timestamp |
| Legible | Data displayed clearly with full history accessible |
| Contemporaneous | Actions recorded at time of occurrence |
| Original | Original records preserved; changes create new versions |
| Accurate | Validation rules enforce data accuracy |
| Complete | Full audit trail with no gaps |
| Consistent | Standardized data entry and validation |
| Enduring | Data stored securely with configurable retention |
| Available | Data accessible for review throughout retention period |
Cohera provides documentation and tools to support your Computer System Validation (CSV) activities:
| Document | Description |
|---|---|
| System Design Specification | Architecture and design documentation |
| Functional Specification | Detailed feature documentation |
| User Requirements Template | Template for defining your requirements |
| IQ Protocol Template | Installation Qualification protocol |
| OQ Protocol Template | Operational Qualification protocol |
| PQ Protocol Template | Performance Qualification protocol |
| Traceability Matrix | Requirements to test traceability |
| SOPs | Standard operating procedures |
┌─────────────────────────────────────────────────────────┐│ VALIDATION ENVIRONMENTS │├─────────────────────────────────────────────────────────┤│ DEVELOPMENT (DEV) ││ - New features and fixes ││ - Not validated │├─────────────────────────────────────────────────────────┤│ QUALIFICATION (UAT) ││ - IQ/OQ/PQ execution ││ - Customer validation testing │├─────────────────────────────────────────────────────────┤│ PRODUCTION (PROD) ││ - Validated, GxP data ││ - Change controlled │└─────────────────────────────────────────────────────────┘All changes to Cohera follow a documented change control process:
| Category | Description | Customer Impact |
|---|---|---|
| Critical | Security patches, data integrity fixes | Immediate deployment with notification |
| Major | New features, significant changes | Advance notice, validation impact assessment |
| Minor | Bug fixes, UI improvements | Release notes, minimal validation impact |
| Configuration | Customer-specific settings | Customer-controlled |
Cohera maintains qualification as a software supplier:
Cohera supports customer and regulatory audits:
Cohera supports data residency requirements:
| Region | Data Center Location |
|---|---|
| US | AWS us-east-1 (N. Virginia) |
| EU | AWS eu-west-1 (Ireland) |
| APAC | AWS ap-northeast-1 (Tokyo) |
Data does not leave the selected region without explicit customer configuration.
21 CFR Part 11
Start with FDA electronic records requirements. Read the guide
EU GMP Annex 11
Start with European computerized systems requirements. Read the guide